文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病医院感染防控

如何开展:共享与再利用数据——预测单克隆抗体和疫苗对耐药影响项目的挑战与解决方案

How to: share and reuse data-challenges and solutions from predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance project.
PubMed 文献 · Clin Microbiol Infect · 2025-01-25

预测单克隆抗体和疫苗对耐药影响(PRIMAVERA)项目通过系统检索识别108项符合数据共享条件的研究,其中8项完成全部法律要求并共享数据集,涵盖4种感染综合征和7种耐药病原体。共享数据已在欧洲临床研究传染病流行病学联盟网络平台公开。文章梳理了数据共享中的挑战与可能解决方案。

要点

  • 系统检索识别108项符合条件研究,其中8项完成法律要求并共享数据。
  • 共享数据涵盖4种感染综合征和7种耐药病原体。
  • 共享数据已在欧洲临床研究传染病流行病学联盟网络平台公开。

核心结论

  • 项目经验预期可用于改进数据共享,所收集数据集可用于未来耐药研究。

研究设计与样本

  • 欧洲研究项目PRIMAVERA,工作包3负责通过系统检索收集历史匿名个体患者数据集。

主要发现

  • 系统检索识别108项符合数据共享条件的研究,其中8项完成全部法律要求并共享数据集。
  • 共享数据涵盖4种感染综合征和7种耐药病原体。
  • 共享数据已在欧洲临床研究传染病流行病学联盟网络平台公开。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data sharing accelerates scientific progress and improves evidence quality. Even though journals and funding institutions require investigators to share data, only a small part of studies made their data publicly available upon publication. The procedures necessary to share retrospective data for reuse in secondary data analysis projects can be cumbersome. OBJECTIVES: Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance is a European research project that aims to develop mathematical models and an epidemiological repository to assess the impact of vaccines and monoclonal antibodies on antimicrobial resistance (AMR). To accomplish the project aim, Work Package 3 was responsible for gathering historical anonymized individual patient datasets. SOURCES: Through a systematic search we have identified 108 eligible studies for data sharing; of which eight have completed all legal requirements and shared their datasets, with data from four infectious syndromes and seven resistant pathogens. The AMR data gathered in Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance project are publicly available in European Clinical Research Alliance on Infectious Disease epidemiology network platform (https://epi-net.eu/primavera/about/anonymized-individual-patient-data/). CONTENT: Challenges and possible solutions in data sharing activities were mapped and discussed: lack of researchers' interest in sharing data, cumbersome ethical and legal requirements, laborious data management procedures, specific requirements for public data access, insufficient training and funding. IMPLICATIONS: We expect that experience gained in this project can be useful to improve data sharing; and that the datasets gathered can be used in future AMR projects.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Guedes M, de la Serna Bazan A, Rubio-Martín E, et al. How to: share and reuse data-challenges and solutions from predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance project. Clin Microbiol Infect. 2025. PMID: 39870351. doi:10.1016/j.cmi.2025.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。